Table 1.
Baseline clinical characteristics of patients with hepatic sarcoidosis.
| Characteristics | Patients (n = 62) |
|---|---|
| Patient age at diagnosis (years), mean ± SD | 51.6 ± 12.1 |
| Female sex, n (%) | 32 (51.6) |
| Ethnicity, n (%) | |
| Caucasian | 50 (80.6) |
| African American | 3 (4.8) |
| Hispanic | 2 (3.2) |
| Other | 7 (11.3) |
| BMI (kg/m2), mean ± SD | 25.0 ± 4.5 |
| Length of follow-up (years), median (range) | 3.0 (0.0–16.25) |
| Extrahepatic involvement, n (%)∗ | |
| Pulmonary | 31 (50.0) |
| Lymphatic | 24 (38.7) |
| Splenic | 11 (17.7) |
| Ocular | 6 (9.7) |
| Parotid | 5 (8.1) |
| Clinical presentation, n (%)† | |
| Asymptomatic | 35 (56.5) |
| Fatigue | 7 (11.3) |
| Abdominal pain | 6 (9.7) |
| Weight loss | 6 (9.7) |
| Fever | 2 (3.2) |
| Jaundice | 1 (1.6) |
| Pruritus | 1 (1.6) |
∗
Involvement of more than 1 organ per patient was possible.
†
More than 1 clinical symptom per patient were possible.